Intensive Care Medicine

, Volume 34, Issue 7, pp 1175–1176 | Cite as

Aprotinin and microvascular thrombosis in cardiac surgery



  1. 1.
    Dixon B, Campbell DJ, Santamaria JD (2008) Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery. Intensive Care Med DOI 10.1007/s00134-008-1042-7
  2. 2.
    Royston D, Bidstrup BP, Taylor KM, Sapsford RN (1987) Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet II:1289–1291CrossRefGoogle Scholar
  3. 3.
    Ranucci M, The European Association of Cardiothoracic Anaesthesiologists (EACTA) (2007) Perioperative haemostasis and coagulation management in cardiac surgery: a European survey. Eur J Anaesthesiol Suppl 24(40):1–13CrossRefGoogle Scholar
  4. 4.
    Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJM, Briët E, Büller HR (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:1940–1947PubMedCrossRefGoogle Scholar
  5. 5.
    Mangano DT, Tudor IC, Dietzel C, The Multicenter Study of Perioperative Ischemia Research Group, The Ischemia Research Education Foundation (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353–365PubMedCrossRefGoogle Scholar
  6. 6.
    Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J, The Multicenter Study of Perioperative Ischemia Research Group, The Ischemia Research and Education Foundation (2007) Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297:471–479PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Department of Anesthesia and Intensive CareIRRCS Policlinico S. DonatoSan Donato Milanese (Milan)Italy

Personalised recommendations